![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication October 14, 2005.
Revised November 18, 2005.
Accepted for publication November 21, 2005.
Etanercept is a tumor necrosis factor antagonist with anti-inflammatory effects. The aim of our study was to evaluate for the first time the therapeutic efficacy of in vivo inhibition of TNF-
in experimental model of spinal cord trauma, which was induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. Spinal cord injury in mice resulted in severe trauma characterized by edema, neutrophil infiltration, and cytokine production that it is followed by recruitment of other inflammatory cells, production of a range of inflammation mediators, tissue damage, apoptosis and disease. Treatment of the mice with etanercept, significantly reduced the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) neutrophils infiltration (MPO evaluation), (3) iNOS, nitrotyrosine, COX2, and cytokines expression (TNF-
and IL-1
), (4) and apoptosis (TUNEL staining and Bax and Bcl-2 expression). In a separate set of experiment we have also clearly demonstrated that TNF-
inhibitor significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, our results clearly demonstrate that treatment with etanercept reduces the development of inflammation and tissue injury events associated with spinal cord trauma.
Key words:
Etanercept, TNF-a, apoptosis, free radical, inflammation, spinal cord injury
This article has been cited by other articles:
![]() |
A. R. Ferguson, R. N. Christensen, J. C. Gensel, B. A. Miller, F. Sun, E. C. Beattie, J. C. Bresnahan, and M. S. Beattie Cell Death after Spinal Cord Injury Is Exacerbated by Rapid TNF{alpha}-Induced Trafficking of GluR2-Lacking AMPARs to the Plasma Membrane J. Neurosci., October 29, 2008; 28(44): 11391 - 11400. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Genovese, E. Esposito, E. Mazzon, R. D. Paola, R. Meli, P. Bramanti, D. Piomelli, A. Calignano, and S. Cuzzocrea Effects of Palmitoylethanolamide on Signaling Pathways Implicated in the Development of Spinal Cord Injury J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 12 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Genovese, E. Esposito, E. Mazzon, C. Muia, R. Di Paola, R. Meli, P. Bramanti, and S. Cuzzocrea Evidence for the Role of Mitogen-Activated Protein Kinase Signaling Pathways in the Development of Spinal Cord Injury J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 100 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fries, C. Muja, C. Crisafulli, S. Cuzzocrea, and E. Mazzon Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G938 - G947. [Abstract] [Full Text] [PDF] |
||||